Lorente 2012.
Study characteristics | ||
Methods | Study design: Parallel‐group RCT Location: Tenerife, Spain Number of centres: 1 Study period: August 2010 to August 2011 Funding source: Hospital funding |
|
Participants | Setting: medical/surgical ICU Inclusion criteria: consecutive patients undergoing invasive mechanical ventilation for at least 24 hours Exclusion criteria: edentulous, aged < 18 years, pregnant, HIV positive, white blood cells < 1000 cells/mm3, solid or haematological tumour, immunosuppressive therapy, mechanical ventilation duration < 24 hours Number randomised: 436 (217/219) Number evaluated: 436 Baseline characteristics: ‐ Intervention group: age: 61.0 ± 15.6 years; M/F: 146/71 ‐ Control group: age: 60.4 ± 16.6 years; M/F: 145/74 |
|
Interventions |
Toothbrushing + 0.12% chlorhexidine gel vs chlorhexidine alone Experimental group (n = 217): oral cleansing performed with 0.12% chlorhexidine‐impregnated gauze, and oral cavity injection, followed by manual brushing of the teeth with a brush impregnated with 0.12% chlorhexidine (tooth by tooth on the anterior and posterior surfaces, the gum line and the tongue for a period of 90 seconds) Control group (n = 219): oral cleansing performed with 0.12% chlorhexidine‐impregnated gauze, and oral cavity injection only In both groups, nurse performed oral care every 8 hours. First endotracheal cuff pressure was tested, oropharyngeal secretions were aspirated, then chlorhexidine‐impregnated gauze was used to cleanse the teeth, tongue and mucosal surfaces, followed by injection of 10 mL 0.12% of chlorhexidine digluconate into oral cavity, and finally after 30 seconds the OParea was suctioned. |
|
Outcomes | 1. Incidence of VAP 2. Duration of ventilation 3. ICU mortality 4. Tracheal colonisation with gram +ve & ‐ve organisms 5. Antibiotic exposure |
|
Notes | Sample size calculation: estimated that 218 participants required in each group to give 80% power and α error of 5%, to show a reduction in VAP from 15% to 7.5% | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | "...a list of random numbers generated with Excel software (Microsoft, Seattle, WA)" |
Allocation concealment (selection bias) | Unclear risk | No information about allocation concealment |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Not possible |
Blinding of outcome assessment (detection bias) All outcomes | Low risk | "The diagnosis of VAP was made by an expert panel, blinded to group assignment". |
Incomplete outcome data (attrition bias) All outcomes | Low risk | All randomised participants are included in the outcome evaluations. |
Selective reporting (reporting bias) | Low risk | Planned outcomes reported in full |
Other bias | Low risk | No other sources of bias identified |